Document is current
Any future updates will be listed below
-
Authors
Abramsohn, Emily M. https://orcid.org/0000-0003-2016-1170
De Ornelas, MariaDelSol
Borson, Soo
Frazier, Cristianne R. M.
Fuller, Charles M.
Grana, Mellissa
Huang, Elbert S.
Jagai, Jyotsna S.
Makelarski, Jennifer A.
Miller, Doriane
Schulman-Green, Dena
Shiu, Eva
Thompson, Katherine
Winslow, Victoria
Wroblewski, Kristen
Lindau, Stacy Tessler
-
Funding
Funding for this research was provided by:
National Institute on Minority Health and Health Disparities (R01MD012630)
National Institute on Aging (R01AG064949)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK127961)
- License Information
-
More Information
Article History
Received: 10 January 2023
Accepted: 3 October 2023
First Online: 21 October 2023
Declarations
:
: Participants in each study provide documentation of informed consent; both trials were approved by the University of Chicago Institutional Review Board (IRB).
: Not applicable.
: Under the terms of Grant Number 1C1CMS330997-01–00 (ST Lindau, PI) from the Department of Health and Human Services, Centers for Medicare & Medicaid Services, we were expected to develop a sustainable business model to continue and support the model that we tested after award funding ended. Dr. Stacy Lindau was the founder and owner of a social impact company, NowPow, LLC, which was acquired by Unite USA, Inc., in 2021. Dr. Lindau was a paid advisor 9/2021–12/2021 and has been an unpaid advisor and holds stock in Unite USA, Inc. (dba Unite Us). Neither the University of Chicago nor UChicago Medicine is endorsing or promoting Unite Us or its business, products, or services. Dr. Lindau is an editor on Female Sexual Dysfunction for UpToDate, Inc. and received royalties < $100/year in 2019 and 2020 for this work. Subsequent royalties have been paid to the University of Chicago. Dr. Lindau owned debt and now equity in an unrelated healthcare company. All other authors have no competing interests to disclose.
